Literature DB >> 19023636

Two young sisters with spinocerebellar ataxia type 2 showing different clinical progression of disease.

Uluç Yiş1, Eray Dirik, Semra Hiz Kurul, Asli Gündoğdu Eken, A Nazli Başak.   

Abstract

Spinocerebellar ataxia type 2 is a neurodegenerative disease caused by a CAG repeat expansion in the ataxin-2 gene. Gain-of-toxic effects caused by expanded polyglutamine tracts are important for the disease pathogenesis and there is an inverse relationship between the number of CAG repeats and the age of onset and clinical severity. Previously, we reported an extended Turkish family with spinocerebellar ataxia type 2 with several affected members in three generations. Two sisters in this generation showed an earlier age of onset (5 and 7 years, respectively) than their father (30 years). In this paper, we present a further interesting finding regarding the disease onset and manifestation in the two sisters. Interestingly, the age of onset was delayed and the clinical severity of the disease was milder in the child who had more CAG repeats (84 vs. 70). This finding suggests that there are other factors contributing to the age of onset and clinical severity in spinocerebellar ataxia type 2 other than the increased CAG repeat.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19023636     DOI: 10.1007/s12311-008-0080-6

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  17 in total

1.  Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis.

Authors:  B P C van de Warrenburg; R J Sinke; C C Verschuuren-Bemelmans; H Scheffer; E R Brunt; P F Ippel; J A Maat-Kievit; D Dooijes; N C Notermans; D Lindhout; N V A M Knoers; H P H Kremer
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

2.  The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia.

Authors:  D H Geschwind; S Perlman; C P Figueroa; L J Treiman; S M Pulst
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

3.  SCA2 trinucleotide expansion in German SCA patients.

Authors:  O Riess; F A Laccone; S Gispert; L Schöls; C Zühlke; A M Vieira-Saecker; S Herlt; K Wessel; J T Epplen; B H Weber; F Kreuz; S Chahrokh-Zadeh; A Meindl; A Lunkes; J Aguiar; M Macek; A Krebsová; M Macek; K Bürk; S Tinschert; I Schreyer; S M Pulst; G Auburger
Journal:  Neurogenetics       Date:  1997-05       Impact factor: 2.660

4.  [Spinocerebellar ataxia type 2 in Cuba. A study of the electrophysiological phenotype and its correlation with clinical and molecular variables].

Authors:  L Velázquez Pérez; L Almaguer Mederos; N Santos Falcón; R Hechavarría; G Sánchez Cruz; H M Paneque
Journal:  Rev Neurol       Date:  2001 Dec 16-31       Impact factor: 0.870

5.  Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families.

Authors:  G Cancel; A Dürr; O Didierjean; G Imbert; K Bürk; A Lezin; S Belal; A Benomar; M Abada-Bendib; C Vial; J Guimarães; H Chneiweiss; G Stevanin; G Yvert; N Abbas; F Saudou; A S Lebre; M Yahyaoui; F Hentati; J C Vernant; T Klockgether; J L Mandel; Y Agid; A Brice
Journal:  Hum Mol Genet       Date:  1997-05       Impact factor: 6.150

6.  Sisters homozygous for the spinocerebellar ataxia type 6 (SCA6)/CACNA1A gene associated with different clinical phenotypes.

Authors:  T Kato; F Tanaka; M Yamamoto; E Yosida; T Indo; H Watanabe; T Yoshiwara; M Doyu; G Sobue
Journal:  Clin Genet       Date:  2000-07       Impact factor: 4.438

7.  Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases.

Authors:  Joana Branco; Ismael Al-Ramahi; Lubna Ukani; Alma M Pérez; Pedro Fernandez-Funez; Diego Rincón-Limas; Juan Botas
Journal:  Hum Mol Genet       Date:  2007-11-05       Impact factor: 6.150

Review 8.  Protein aggregation and neurodegenerative disease.

Authors:  Christopher A Ross; Michelle A Poirier
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

9.  Spinocerebellar ataxia type 2 (SCA2) presenting with ophthalmoplegia and developmental delay in infancy.

Authors:  Paolo Moretti; Maria Blazo; Leonardo Garcia; Dawna Armstrong; Richard Alan Lewis; Benjamin Roa; Fernando Scaglia
Journal:  Am J Med Genet A       Date:  2004-02-01       Impact factor: 2.802

10.  Spinocerebellar ataxia type 2 (SCA 2) in an infant with extreme CAG repeat expansion.

Authors:  D Babovic-Vuksanovic; K Snow; M C Patterson; V V Michels
Journal:  Am J Med Genet       Date:  1998-10-12
View more
  2 in total

1.  An electrophysiological study of visual processing in spinocerebellar ataxia type 2 (SCA2).

Authors:  Jan Kremlacek; Martin Valis; Jiri Masopust; Ales Urban; Alena Zumrova; Radomir Talab; Miroslav Kuba; Zuzana Kubova; Jana Langrova
Journal:  Cerebellum       Date:  2011-03       Impact factor: 3.847

2.  The Respiratory Phenotype of Rodent Models of Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia.

Authors:  Anna F Fusco; Angela L McCall; Justin S Dhindsa; Logan A Pucci; Laura M Strickland; Amanda F Kahn; Mai K ElMallah
Journal:  J Neuroinflamm Neurodegener Dis       Date:  2019-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.